CAS 95403-16-0

Formula: C17H16O5

InChI: InChI=1S/C17H16O5/c1-8-15(20)9(2)17-14(16(8)21)12(19)7-13(22-17)10-3-5-11(18)6-4-10/h3-6,13,18,20-21H,7H2,1-2H3

InChI key: DYHOLQACRGJEHX-UHFFFAOYSA-N

SMILES: CC1=C(C(=C2C(=C1O)C(=O)CC(O2)C3=CC=C(C=C3)O)C)O

Farrerol

CAS: 95403-16-0

Oxygen-heterocyclic compound

Formula: C₁₇H₁₆O₅

Purezza: ≥ 95.0 % (HPLC)

Colore e forma: Powder

Peso molecolare: 300.31

Ref: 5G-82539

Farrerol

Prodotto controllato

CAS: 95403-16-0

Applications Farrerol is a modulator of ERK1/2 activity which regulates occludin expression in cells. This affects tight junctions in human cells which is related to various epidermal skin diseases and ailments.
References Lai-Cheong, J. et al.: J. Invest. Dermatol., 127, 2713 (2007); Li, J. et al.: Eur. J. Pharm., 734, 9 (2014);

Formula: C₁₇H₁₆O₅

Colore e forma: Neat

Peso molecolare: 300.31

Ref: TR-F101060

Farrerol

CAS: 95403-16-0

Farrerol is a natural compound that inhibits the angiotensin system and has been shown to have anti-inflammatory effects. It can be used for the treatment of inflammatory diseases, including arthritis, asthma, and psoriasis. Farrerol has also been shown to inhibit the production of collagenase in human serum, which may be due to its ability to suppress the activity of neutrophils. This molecule also has neuroprotective properties and can inhibit neuronal death after injury by inhibiting microglia activation. Farrerol is structurally similar to a polyketide synthase (PKS) intermediate and activates toll-like receptor 4 (TLR4) pathways.

Formula: C₁₇H₁₆O₅

Purezza: Min. 95%

Peso molecolare: 300.31 g/mol

Ref: 3D-VDA40316